disulfiram has been researched along with Idiopathic Parkinson Disease in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " A toxic product of lipid peroxidation, (±)-4-hydroxy-2E-nonenal (HNE) leads to membrane disruption and formation of HNE-protein adducts and such adducts have been detected in PD brain tissues." | 1.38 | Modulation of aldehyde dehydrogenase activity affects (±)-4-hydroxy-2E-nonenal (HNE) toxicity and HNE-protein adduct levels in PC12 cells. ( Kong, D; Kotraiah, V, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, D | 1 |
| Kotraiah, V | 1 |
| Charles, V | 1 |
| Boulvin, S | 1 |
| Haven, F | 1 |
| Gille, M | 1 |
| Arushanian, EB | 1 |
| Birket-Smith, E | 1 |
| Andersen, JV | 1 |
| Presthus, J | 1 |
| Bianchine, JR | 1 |
| Sunyapridakul, L | 1 |
| Duvoisin, RC | 1 |
| Marsden, CD | 1 |
| Braham, J | 1 |
2 reviews available for disulfiram and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
[Other trials with drug therapy in parkinsonism].
Topics: 5-Hydroxytryptophan; Amitriptyline; Animals; Dihydroxyphenylalanine; Disulfiram; Drug Evaluation; Dr | 1973 |
Individualization of levodopa therapy.
Topics: Amantadine; Amphetamine; Anesthetics; Animals; Antihypertensive Agents; Apomorphine; Arrhythmias, Ca | 1974 |
6 other studies available for disulfiram and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Modulation of aldehyde dehydrogenase activity affects (±)-4-hydroxy-2E-nonenal (HNE) toxicity and HNE-protein adduct levels in PC12 cells.
Topics: Aldehyde Dehydrogenase 1 Family; Aldehydes; Animals; Cell Death; Disulfiram; DNA Adducts; Lipid Pero | 2012 |
[Wernicke's encephalopathy associated with chronic disulfiram intoxication].
Topics: Adult; Disulfiram; Humans; Magnetic Resonance Imaging; Male; Parkinson Disease; Wernicke Encephalopa | 2006 |
[The phenomenon of experimental motor retardation as one of the manifestations of the Parkinsonian syndrome].
Topics: Amphetamine; Animals; Catecholamines; Cats; Caudate Nucleus; Chlorpromazine; Dihydroergotoxine; Dise | 1975 |
Treatment of side-effects of levodopa.
Topics: Dihydroxyphenylalanine; Disulfiram; Humans; Hyperkinesis; Hypertension; Parkinson Disease | 1973 |
Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi.
Topics: Animals; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Disease Models, Animal; Disulfiram; Dose | 1974 |
Adjuvants to L-dopa for Parkinsonism.
Topics: Animals; Cats; Dihydroxyphenylalanine; Disulfiram; Drug Synergism; Humans; Isoniazid; Parkinson Dise | 1970 |